These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 15665654

  • 1. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA, Margolis K, Luepker RV, Arnett DK.
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [Abstract] [Full Text] [Related]

  • 2. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA, Wee CC.
    J Womens Health (Larchmt); 2005 Nov; 14(6):507-14. PubMed ID: 16115005
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 6. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM, Korenstein D, Halm EA.
    Menopause; 2007 May; 14(2):216-22. PubMed ID: 17179789
    [Abstract] [Full Text] [Related]

  • 7. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG.
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [Abstract] [Full Text] [Related]

  • 8. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 12. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 13. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 14. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U, van den Brûle F, Pintiaux A, Foidart JM.
    Rev Med Liege; 2002 Aug 01; 57(8):556-62. PubMed ID: 12405030
    [Abstract] [Full Text] [Related]

  • 15. Colorectal cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study.
    Nazeri K, Khatibi A, Nyberg P, Agardh CD, Lidfeldt J, Samsioe G.
    Gynecol Endocrinol; 2006 Aug 01; 22(8):416-22. PubMed ID: 17012102
    [Abstract] [Full Text] [Related]

  • 16. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.
    Exp Clin Endocrinol Diabetes; 2005 Oct 01; 113(9):529-33. PubMed ID: 16235155
    [Abstract] [Full Text] [Related]

  • 17. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gómez MS, Sarrá S.
    Menopause; 2004 Oct 01; 11(1):57-61. PubMed ID: 14716183
    [Abstract] [Full Text] [Related]

  • 18. [Lessons from the Women's Health Initiative (WHI) using hormone replacement therapy with regard to heart disease--the dream that has been broken?].
    Pines A.
    Harefuah; 2003 Mar 01; 142(3):163-5, 240. PubMed ID: 12696464
    [Abstract] [Full Text] [Related]

  • 19. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S, Jirapinyo M, Chaovisitsaree S, Wipatavit V, Bunyaviroch S, Kanluan B, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N.
    J Med Assoc Thai; 2007 Apr 01; 90(4):628-35. PubMed ID: 17487115
    [Abstract] [Full Text] [Related]

  • 20. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA, Davis RB, Wee CC.
    Womens Health Issues; 2005 Apr 01; 15(4):187-95. PubMed ID: 16051110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.